Nyasha Bakare

1.8k total citations · 1 hit paper
18 papers, 1.2k citations indexed

About

Nyasha Bakare is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Nyasha Bakare has authored 18 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 8 papers in Epidemiology and 6 papers in Immunology. Recurrent topics in Nyasha Bakare's work include Tuberculosis Research and Epidemiology (8 papers), HIV Research and Treatment (5 papers) and Immunotherapy and Immune Responses (5 papers). Nyasha Bakare is often cited by papers focused on Tuberculosis Research and Epidemiology (8 papers), HIV Research and Treatment (5 papers) and Immunotherapy and Immune Responses (5 papers). Nyasha Bakare collaborates with scholars based in United States, France and Belgium. Nyasha Bakare's co-authors include Nacer Lounis, Koen Andries, Alexander S. Pym, Rolf P. G. van Heeswijk, Tine De Marez, I. А. Vаsilyevа, Paul Meyvisch, Brian Dannemann, Martin P. Grobusch and Vaira Leimane and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and PLoS Medicine.

In The Last Decade

Nyasha Bakare

18 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Multidrug-Resistant Tuberculosis and Culture Conversion with Bedaquiline

2014 505 citations Andreas H. Diacon, Alexander S. Pym et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Nyasha Bakare

Since Specialization

Citations

This map shows the geographic impact of Nyasha Bakare's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nyasha Bakare with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nyasha Bakare more than expected).

Fields of papers citing papers by Nyasha Bakare

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nyasha Bakare. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nyasha Bakare. The network helps show where Nyasha Bakare may publish in the future.

Co-authorship network of co-authors of Nyasha Bakare

This figure shows the co-authorship network connecting the top 25 collaborators of Nyasha Bakare. A scholar is included among the top collaborators of Nyasha Bakare based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nyasha Bakare. Nyasha Bakare is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Bedaquiline Monotherapy for Multibacillary Leprosy 2024 ·New England Journal of Medicine ·Jaison Antônio Barreto, Patrícia Sammarco Rosa, Linda B. Adams, Zuleima Aguilar, Nyasha Bakare, Sandra R. Chaplan, (unknown), Étienne Ernault, (unknown), Nacer Lounis, Dawn Millington, James A. Palmer, Bart Remmerie, Miao Wang, (unknown), Richard W. Truman, (unknown)	4
2	A prospective patient registry to monitor safety, effectiveness, and utilisation of bedaquiline in patients with multidrug-resistant tuberculosis in South Korea 2023 ·BMC Infectious Diseases ·Tae Sun Shim, (unknown), Jeongha Mok, Seung Heon Lee, Yong-Soo Kwon, Jae Chol Choi, (unknown), (unknown), (unknown), (unknown), Kourtney J. Davis, (unknown), Ji Hyun Kim, (unknown), Nyasha Bakare	4
3	Bedaquiline safety, efficacy, utilization and emergence of resistance following treatment of multidrug-resistant tuberculosis patients in South Africa: a retrospective cohort analysis 2022 ·BMC Infectious Diseases ·(unknown), Norbert Ndjeka, Lawrence Mbuagbaw, Koné Kaniga, (unknown), (unknown), (unknown), Kourtney J. Davis, (unknown), (unknown), (unknown), (unknown), Shaheed Vally Omar, Nyasha Bakare	22
4	Impact of Rv0678 mutations on patients with drug-resistant TB treated with bedaquiline 2022 ·The International Journal of Tuberculosis and Lung Disease ·Koné Kaniga, Nacer Lounis, (unknown), Nyasha Bakare, Koen Andries	8
5	Bedaquiline for multidrug-resistant TB in paediatric patients 2021 ·The International Journal of Tuberculosis and Lung Disease ·Ronelle Moodliar, (unknown), (unknown), (unknown), Stefaan Rossenu, (unknown), (unknown), (unknown), Nacer Lounis, (unknown), Nyasha Bakare, (unknown)	14
6	Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant Tuberculosis 2019 ·Emerging infectious diseases ·Lawrence Mbuagbaw, Lorenzo Guglielmetti, Catherine Hewison, Nyasha Bakare, Mathieu Bastard, Éric Caumes, (unknown), J. Robert, Nicolas Véziris, Naira Khachatryan, (unknown), Արմեն Հայրապետյան, Zaza Avaliani, Holger J. Schünemann, Christian Lienhardt	61
7	Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis 2015 ·European Respiratory Journal ·Alexander S. Pym, Andreas H. Diacon, Shenjie Tang, Francesca Conradie, Manfred Danilovitš, Charoen Chuchottaworn, I. А. Vаsilyevа, Koen Andries, Nyasha Bakare, Tine De Marez, (unknown), Nacer Lounis, Paul Meyvisch, Ben Van Baelen, Rolf P. G. van Heeswijk, Brian Dannemann	226
8	Exploitation of Langerhans cells for in vivo DNA vaccine delivery into the lymph nodes 2014 ·Gene Therapy ·Enikő R. Tőke, (unknown), (unknown), E Somogyi, (unknown), (unknown), R. Szipöcs, Attila Kolonics, Bernard Malissen, Franco Lori, Jeffrey Trocio, Nyasha Bakare, Ferenc Horkay, Nikolaus Romani, Christoph H. Tripp, Patrizia Stoitzner, Julianna Lisziewicz	17
9	Multidrug-Resistant Tuberculosis and Culture Conversion with Bedaquiline breakdown → 2014 ·New England Journal of Medicine ·Andreas H. Diacon, Alexander S. Pym, Martin P. Grobusch, (unknown), Eduardo Gotuzzo, I. А. Vаsilyevа, Vaira Leimane, Koen Andries, Nyasha Bakare, Tine De Marez, (unknown), Nacer Lounis, Paul Meyvisch, Els De Paepe, Rolf P. G. van Heeswijk, Brian Dannemann	505
10	Single DermaVir Immunization: Dose-Dependent Expansion of Precursor/Memory T Cells against All HIV Antigens in HIV-1 Infected Individuals 2012 ·PLoS ONE ·Julianna Lisziewicz, Nyasha Bakare, Sandra A. Calarota, Dénes Bánhegyi, János Szlávik, Eszter Újhelyi, Enikő R. Tőke, (unknown), (unknown), Brigitte Autran, Franco Lori	51
11	Global Pharmacovigilance for Antiretroviral Drugs: Overcoming Contrasting Priorities 2011 ·PLoS Medicine ·Nyasha Bakare, I. Ralph Edwards, Andy Stergachis, Shanthi Pal, Charles B. Holmes, Marie Lindquist, Chris Duncombe, Alex Dodoo, (unknown), Jude Nwokike, Ricardo Kuchenbecker, Judith A. Aberg, Veronica Miller, Jur Strobos	16
12	Severe combined immunodeficiency (SCID) and rotavirus vaccination: Reports to the Vaccine Adverse Events Reporting System (VAERS) 2010 ·Vaccine ·Nyasha Bakare, David Menschik, Rosemary Tiernan, Wei Hua, David Martin	53
13	HIV-1 prophylactic vaccine comprised of topical DermaVir prime and protein boost elicits cellular immune responses and controls pathogenic R5 SHIV162P3 2007 ·Virology ·Anthony D. Cristillo, Julianna Lisziewicz, Leilei He, Franco Lori, Lindsey Galmin, Jeffrey Trocio, (unknown), Lucia Whitman, Lauren Hudacik, Nyasha Bakare, Stephen Whitney, (unknown), John J. Suschak, (unknown), (unknown), Vaniambadi S. Kalyanaraman, Phillip D. Markham, Ranajit Pal	27
14	Lowering the Dose of Hydroxyurea Minimizes Toxicity and Maximizes Anti-HIV Potency 2005 ·AIDS Research and Human Retroviruses ·Franco Lori, Richard B. Pollard, Lucia Whitman, Nyasha Bakare, Gary Blick, (unknown), Andrea Foli, D. M. Peterson, Alan M. Tennenberg, Shannon Schrader, Bruce Rashbaum, Charles Farthing, (unknown), D. B. Norris, (unknown), Ian Frank, (unknown), (unknown), David M. Asmuth, Julianna Lisziewicz	9
15	DermaVir, a novel HIV immunisation technology 2005 ·Vaccine ·Franco Lori, Jeffrey Trocio, Nyasha Bakare, Libby A. Kelly, Julianna Lisziewicz	27
16	DermaVir: A Novel Topical Vaccine for HIV/AIDS 2005 ·Journal of Investigative Dermatology ·Julianna Lisziewicz, Jeffrey Trocio, Lucia Whitman, Georg Varga, Jianqing Xu, Nyasha Bakare, Patrick Erbacher, Cecil H. Fox, Ruth Woodward, Phil Markham, Suresh K. Arya, (unknown), Franco Lori	70
17	Optimal suppression of HIV replication by low-dose hydroxyurea through the combination of antiviral and cytostatic (‘virostatic’) mechanisms 2005 ·AIDS ·Franco Lori, Andrea Foli, (unknown), (unknown), Lucia Whitman, Nyasha Bakare, Richard B. Pollard, Julianna Lisziewicz	20
18	Control of viral rebound through therapeutic immunization with DermaVir 2004 ·AIDS ·Julianna Lisziewicz, Jeffrey Trocio, Jianqing Xu, Lucia Whitman, (unknown), Nyasha Bakare, Mark G. Lewis, Wendeline Wagner, Angela Pistorio, Suresh K. Arya, Franco Lori	50

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact